Xu D - Search Results

1

Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies.

Jiang Y, Li W, Yu L, Liu J, Xin G, Yan H, Sun P, Zhang H, Xu D, Niu J. Jiang Y, et al. Among authors: xu d. Cell Mol Immunol. 2011 Jan;8(1):75-82. doi: 10.1038/cmi.2010.37. Epub 2010 Oct 4. Cell Mol Immunol. 2011. PMID: 20921939 Free PMC article.

2

IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population.

Shi X, Pan Y, Wang M, Wang D, Li W, Jiang T, Zhang P, Chi X, Jiang Y, Gao Y, Zhong J, Sun B, Xu D, Jiang J, Niu J. Shi X, et al. Among authors: xu d. PLoS One. 2012;7(5):e37054. doi: 10.1371/journal.pone.0037054. Epub 2012 May 23. PLoS One. 2012. PMID: 22649509 Free PMC article.

3

Antiviral treatment alters the frequency of activating and inhibitory receptor-expressing natural killer cells in chronic hepatitis B virus infected patients.

Lv J, Jin Q, Sun H, Chi X, Hu X, Yan H, Pan Y, Xiao W, Tian Z, Hou J, Xu D, Tu Z, Niu J. Lv J, et al. Among authors: xu d. Mediators Inflamm. 2012;2012:804043. doi: 10.1155/2012/804043. Epub 2012 Dec 10. Mediators Inflamm. 2012. PMID: 23304062 Free PMC article. Clinical Trial.

4

Antiviral treatment improves disrupted peripheral B lymphocyte homeostasis in chronic hepatitis B virus-infected patients.

Sun H, Lv J, Tu Z, Hu X, Yan H, Pan Y, Xu D, Lian Z, Chi X, Niu J. Sun H, et al. Among authors: xu d. Exp Biol Med (Maywood). 2013 Nov 1;238(11):1275-83. doi: 10.1177/1535370213502626. Epub 2013 Oct 1. Exp Biol Med (Maywood). 2013. PMID: 24085784 Clinical Trial.

5

IL28B is associated with outcomes of chronic HBV infection.

Shi X, Chi X, Pan Y, Gao Y, Li W, Yang C, Zhong J, Xu D, Zhang M, Minuk G, Jiang J, Niu J. Shi X, et al. Among authors: xu d. Yonsei Med J. 2015 May;56(3):625-33. doi: 10.3349/ymj.2015.56.3.625. Yonsei Med J. 2015. PMID: 25837166 Free PMC article.

6

IL-33 Inhibits Hepatitis B Virus through Its Receptor ST2 in Hydrodynamic HBV Mouse Model.

Gao X, Chi X, Wang X, Wu R, Xu H, Zhan M, Li D, Ding Y, Xu D, Niu J. Gao X, et al. Among authors: xu d, xu h. Mediators Inflamm. 2020 Apr 28;2020:1403163. doi: 10.1155/2020/1403163. eCollection 2020. Mediators Inflamm. 2020. PMID: 32410845 Free PMC article.

7

Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice.

Qiu C, Li Y, Li M, Li M, Liu X, McSharry C, Xu D. Qiu C, et al. Among authors: xu d. Immunology. 2013 Jan;138(1):76-82. doi: 10.1111/imm.12020. Immunology. 2013. PMID: 23078031 Free PMC article.

8

IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background.

Xu D, Trajkovic V, Hunter D, Leung BP, Schulz K, Gracie JA, McInnes IB, Liew FY. Xu D, et al. Eur J Immunol. 2000 Nov;30(11):3147-56. doi: 10.1002/1521-4141(200011)30:11<3147::AID-IMMU3147>3.0.CO;2-J. Eur J Immunol. 2000. PMID: 11093129 Free article.

9

Expression and function of Toll-like receptor on T cells.

Xu D, Komai-Koma M, Liew FY. Xu D, et al. Cell Immunol. 2005 Feb;233(2):85-9. doi: 10.1016/j.cellimm.2005.04.019. Cell Immunol. 2005. Retraction in: Cell Immunol. 2013 Feb;281(2):170. doi: 10.1016/j.cellimm.2013.04.002 PMID: 15950961 Retracted. Review.

10

Direct and indirect role of Toll-like receptors in T cell mediated immunity.

Xu D, Liu H, Komai-Koma M. Xu D, et al. Cell Mol Immunol. 2004 Aug;1(4):239-46. Cell Mol Immunol. 2004. PMID: 16225766 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,010 results

Search Page

Filters